Nimustine Hydrochloride

Nimustine Hydrochloride (CAS No.: 55661-38-6) is a synthetic small molecule nitrosourea and alkylating research compound, representing the hydrochloride salt form of nimustine and broadly categorized within DNA damaging agents used in oncology focused experimental pharmacology and mechanism of action studies; in biomedical research settings, it is primarily employed to investigate covalent DNA modification processes, including interstrand crosslink formation and DNA strand break associated damage, with downstream activation of DNA damage response networks and stress signaling cascades such as p38 MAPK and JNK, alongside disruption of replication associated genomic integrity and suppression of macromolecular synthesis in proliferative cell systems. The functional background of this molecule is linked to its electrophilic reactivity profile characteristic of nitrosourea class agents, making it a useful tool for studying genotoxic stress biology, checkpoint signaling, apoptosis associated cellular outcomes, and resistance mechanisms involving DNA repair capacity. Reported in vitro effects are generally described across nanomolar to micromolar concentration ranges depending on cell type, exposure duration, and assay endpoint, while precise potency metrics vary across experimental platforms and should be determined under study specific conditions. Typical research applications include use in cultured tumor derived cell lines for cytotoxicity and pathway interrogation, in comparative screening workflows for DNA damage sensitizers or combination strategy discovery, and in preclinical animal based oncology models for pharmacodynamic and response biomarker evaluation, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.